Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (annual application deadline, projected)
Funding Amounts: Not specified; varies by project and initiative.
Summary: Supports U.S. organizations advancing health equity for Black women impacted by triple-negative breast cancer by addressing systemic disparities and social determinants of health.